Results 21 to 30 of about 543,179 (266)
EFSA Journal, 2012 The Scientific Panel on Plant Protection Products and their Residues (PPR Panel) of EFSA was asked to make an inventory of protected crop systems (e.g.
EFSA Panel on Plant Protection Products and their Residues (PPR)
doaj +1 more source
Scientific Opinion on the Science behind the Revision of the Guidance Document on Dermal Absorption
EFSA Journal, 2011 This opinion provides the relevant data, evaluations and references that support the criteria proposed in the new draft guidance needed to facilitate assessment of dermal absorption of plant protection products (PPPs) under Directive 91/414/EEC[1] and ...
EFSA Panel on Plant Protection Products and their Residues (PPR)
doaj +1 more source
EFSA Journal, 2010 The European Food Safety Authority (EFSA) asked the Panel to prepare a revision of the Guidance Document on persistence in soil (SANCO/9188VI/1997 of 12 July 2000) as scientific knowledge in this field has evolved in recent years.
EFSA Panel of the Plant Protection Products and their Residues
doaj +1 more source
Plant Products as Antimicrobial Agents [PDF]
Clinical Microbiology Reviews, 1999 SUMMARY The use of and search for drugs and dietary supplements derived from plants have accelerated in recent years. Ethnopharmacologists, botanists, microbiologists, and natural-products chemists are combing the Earth for phytochemicals and “leads” which could be developed for treatment of infectious diseases. While 25 to 50%
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Children with sickle cell disease (SCD) face multiple acute and chronic medical complications that may impact their quality of life as reported by patients themselves. Health‐related social needs (HRSNs), such as food and housing insecurity, are common in people with SCD, but the association between HRSNs and patient‐reported ...
Sarah J. Marks +5 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar +7 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction The use of herbal medical preparation (HMP) is rising among pediatric oncology patients, often to manage treatment‐related symptoms. Their effectiveness remains uncertain, and the risk of herb–drug interactions is underestimated.
Orianne Mahot +6 more
wiley +1 more source
Plant production systems for vaccines
Expert Review of Vaccines, 2003 Plants offer an attractive alternative for the production and delivery of subunit vaccines. Various antigens have been expressed at sufficiently high levels in plants to render vaccine development practical. An increasing body of evidence demonstrates that these plant-produced antigens can induce immunogenic responses and confer protection when ...
Stephen J, Streatfield, John A, Howard
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Pediatric radiation therapy presents unique challenges compared to adult treatments, including those of immobilization, potential need for sedation, and the critical importance of accurate, reproducible positioning. Additionally, heightened attention to imaging doses is necessary to minimize long‐term toxicity in survivors.
Parham Alaei +17 more
wiley +1 more source
EFSA Journal, 2012 The PPR Panel was asked to deliver a scientific opinion on the science behind the development of a risk assessment of plant protection products on bees (Apis mellifera, Bombus spp. and solitary bees).
EFSA Panel on Plant Protection Products and their Residues (PPR)
doaj +1 more source